ATF6alpha Promotes Astroglial Activation and Neuronal Survival in a Chronic Mouse Model of Parkinson's Disease

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Hashida, Koji ^a,b   Kitao, Yasuko ^a,b   Sudo, Hirofumi ^a,b   Awa, Yoshitaka ^a,b   Maeda, Shinichiro ^a,b   Mori, Kazutoshi ^b,c   Takahashi, Ryosuke ^b,c   Iinuma, Munekazu ^d   Hori, Osamu ^a,b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACTIVATING TRANSCRIPTION FACTOR 4; ACTIVATING TRANSCRIPTION FACTOR 6; ACTIVATING TRANSCRIPTION FACTOR 6 ALPHA; BRAIN DERIVED NEUROTROPHIC FACTOR; ESTROGEN RECEPTOR; GLUCOSE REGULATED PROTEIN 78; PROBENECID; TANGERETIN; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ATF6ALPHA GENE; BIOACCUMULATION; CELL SURVIVAL; CHOP GENE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; GENE; GENE DELETION; GENE EXPRESSION; GENE TARGETING; HEME OXYGENASE 1 GENE; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL STIMULATION; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; UNFOLDED PROTEIN RESPONSE; XCT GENE;

ACTIVATING TRANSCRIPTION FACTOR 6; ANIMALS; ASTROCYTES; CELL SURVIVAL; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GENE DELETION; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE, SECONDARY; UBIQUITIN; UNFOLDED PROTEIN RESPONSE;

MUS;

EID: 84868135034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047950     Document Type: Article

References (26)

1. Dauer W, Przedborski S, (2003) Parkinson's disease: mechanisms and models. Neuron Sep 11 39(6): 889-909.
2. Shimohama S, Sawada H, Kitamura Y, Taniguchi T, (2003) Disease model: Parkinson's disease. Trends Mol Med. Aug 9(8): 360-365.
3. Langston JW, Ballard P, Tetrud JW, Irwin I, (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. Feb 25 219(4587): 979-980.
4. Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS, (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience. 106(3): 589-601.
5. Schintu N, Frau L, Ibba M, Garau A, Carboni E, et al. (2009) Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease. Neurotox Res. Aug 16(2): 127-139.
6. Walter P, Ron D, (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science. Nov 25 334(6059): 1081-1086.
7. Lewerenz J, Maher P, (2009) Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J Biol Chem. Jan 9 284(2): 1106-1115.
8. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, et al. (2002) Endoplasmic reticulum stress and the unfolded protein stress response in cellular models of Parkinson's disease. J. Neurosci. 22(24): 10690-10698.
9. Holtz WA, O'Malley KL, (2003) Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem. 278(21): 19367-77.
10. Kitao Y, Imai Y, Ozawa K, Kataoka A, Ikeda T, et al. (2007) Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum Mol Genet. 16(1): 50-60.
11. Takano K, Tabata Y, Kitao Y, Murakami R, Suzuki H, et al. (2007) Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin. Am J Physiol Cell Physiol. 292(1): C353-61.
12. Egawa N, Yamamoto K, Inoue H, Hikawa R, Nishi K, et al. (2011) The endoplasmic reticulum stress sensor, ATF6α, protects against neurotoxin-induced dopaminergic neuronal death. J Biol Chem. 286(10): 7947-57.
13. Tanaka T, Umemura K, Iinuma M, Mizuno M, (1987) Synthesis of Flavonoids in Scutellaria baicalensis. Yakugaku Zasshi. 107: 315-317.
14. Yamamoto K, Sato T, Matsui T, Sato M, Okada T, et al. (2007) Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev Cell. 13(3): 365-376.
15. Yamaguchi A, Hori O, Stern DM, Hartmann E, Ogawa S, et al. (1999) Stress-associated endoplasmic reticulum protein 1 (SERP1)/Ribosome-associated membrane protein 4 (RAMP4) stabilizes membrane proteins during stress and facilitates subsequent glycosylation. J Cell Biol. 147(6): 1195-1204.
16. Maeda Y, Matsumoto M, Hori O, Kuwabara K, Ogawa S, et al. (1994) Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med. 180(6): 2297-2308.
17. Maragakis NJ, Rothstein JD, (2006) Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol. 2(12): 679-89.
18. Kang W, Hébert JM, (2011) Signaling pathways in reactive astrocytes, a genetic perspective. Mol Neurobiol. 43(3): 147-54.
19. Holtz WA, Turetzky JM, Jong YJ, O'Malley KL, (2006) Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics. J Neurochem. 99(1): 54-69.
20. Silva RM, Ries V, Oo TF, Yarygina O, Jackson-Lewis V, et al. (2005) CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J Neurochem. 95(4): 974-986.
21. Hori O, Matsumoto M, Kuwabara K, Maeda Y, Ueda H, et al. (1996) Exposure of astrocytes to hypoxia/reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. J Neurochem. 66(3): 973-979.
22. Tamatani M, Matsuyama T, Yamaguchi A, Mitsuda N, Tsukamoto Y, et al. (2001) ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med. 7(3): 317-23.
23. Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A, et al. (2008) ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Cell Struct Funct. 33(1): 75-89.
24. Kimura K, Yamada T, Matsumoto M, Kido Y, Hosooka T, et al. (2012) Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation. Diabetes. 61(1): 61-73.
25. Datla KP, Christidou M, Widmer WW, Rooprai HK, Dexter DT, (2001) Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport. 12(17): 3871-5.
26. Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, et al. (2012) Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci. 32(10): 3306-20.